Advances continue to be made in the field of antiretroviral therapy. New agents are progressing through various stages of preclinical and clinical development. New studies add to our understanding of how best to use the antiretroviral agents that are already available for clinical use. This article reports on antiretroviral therapy-related presentations made at the 15th Conference on Retroviruses and Opportunistic Infections (CROI 2008) which took place on February 3-6, 2008 in Boston, Massachusetts.
|Original language||English (US)|
|Number of pages||5|
|Journal||Drugs of the Future|
|State||Published - Jun 1 2008|
ASJC Scopus subject areas
- Pharmacology (medical)